Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2008-3-4
pubmed:abstractText
Tpn is a member of the MHC class I loading complex and functions to bridge the TAP peptide transporter to MHC class I molecules. Metastatic human carcinomas often express low levels of the antigen-processing components Tapasin and TAP and display few functional surface MHC class I molecules. As a result, carcinomas are unrecognizable by effector CTLs. The aim of this study is to examine if Tapasin (Tpn) plays a critical role in the escape of tumors from immunologic recognition.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1494-501
pubmed:meshHeading
pubmed-meshheading:18316574-ATP-Binding Cassette Transporters, pubmed-meshheading:18316574-Adenoviridae, pubmed-meshheading:18316574-Animals, pubmed-meshheading:18316574-Antigen Presentation, pubmed-meshheading:18316574-CD4-Positive T-Lymphocytes, pubmed-meshheading:18316574-CD8-Positive T-Lymphocytes, pubmed-meshheading:18316574-Cell Line, Tumor, pubmed-meshheading:18316574-Cross-Priming, pubmed-meshheading:18316574-Dendritic Cells, pubmed-meshheading:18316574-Disease-Free Survival, pubmed-meshheading:18316574-Histocompatibility Antigens Class I, pubmed-meshheading:18316574-Humans, pubmed-meshheading:18316574-Lung Neoplasms, pubmed-meshheading:18316574-Lymphocytes, Tumor-Infiltrating, pubmed-meshheading:18316574-Membrane Transport Proteins, pubmed-meshheading:18316574-Mice, pubmed-meshheading:18316574-Mice, Inbred C57BL, pubmed-meshheading:18316574-Spleen, pubmed-meshheading:18316574-Survival Rate, pubmed-meshheading:18316574-T-Lymphocytes, Cytotoxic
pubmed:year
2008
pubmed:articleTitle
Combining the antigen processing components TAP and Tapasin elicits enhanced tumor-free survival.
pubmed:affiliation
Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't